Andreas Wicki, Director at Pacira Pharmaceuticals, Inc. (PCRX), sold 25,600 shares at $47.07 ($1.2M) on 2018-11-16, disclosed to the SEC on 2018-11-19.
Open-market sale of $1.2M PCRX by Director. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $46.79 | 22,100 | $1.0M | 86.3% |
| 2 | $47.07 | 3,500 | $165K | 13.7% |
| Total | $46.83 avg | 25,600 | $1.2M | 100% |
| Filing → |
| HRMY | SELL | 2022-11-16 | $6.1M | — | Filing → |
| HRMY | SELL | 2022-11-10 | $15.2M | — | Filing → |
| HRMY | SELL | 2022-11-04 | $68.2M | — | Filing → |